Drugs / ADC189 tablets
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06507813 | Aug 2024 → Jan 2025 | influenza | Jiaxing AnDiCon Biotech Co.,Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ADC189 tablets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06507813 ↗ |
| Route | Oral | “The study evaluates the pharmacokinetics, safety and efficacy of ADC189 tablets/granules following a single oral dose in children aged 2 to 11 years with influenza.” NCT06507813 ↗ |